Your source for the latest medtech news from AdvaMed® and our members.
ReGelTec, Inc., announced that the U.S. Food and Drug Administration has approved an IDE for the company’s pivotal study to support premarket approval of its HYDRAFIL® System. The HYDRAFIL System…
Today, AdvaMed, The Medtech Association®, announced the lineup of speakers for The MedTech Conference, hosted October 9-11, 2023 in Anaheim, California. The annual event is the largest gathering for the…
Today, AdvaMed, The Medtech Association®, announced Suzanne Winter, President and CEO of Accuray, a leading manufacturer of life-saving radiotherapy systems, will head the organization’s radiation therapy (RT) sector. In this…
AdvaMed, The Medtech Association®, announced that William Longfield, former Chairman and CEO of C.R. Bard, Inc. and founder of the Cambridge Group, will receive the medtech industry’s most prestigious award,…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
Today, following a legislative hearing on improving seniors’ access to innovative medical devices and technologies, AdvaMed® President and CEO Scott Whitaker commended the House Energy and Commerce Committee’s Subcommittee on…
Today, AdvaMed, The Medtech Association®, submitted a letter to the House Committee on Oversight and Accountability regarding the Committee’s consideration of an issue that threatens to undermine the foundations of…
AdvaMed, The Medtech Association®, released the findings of a new national poll exploring the public perceptions of the use of artificial intelligence (AI) in health care. The poll found that…
AdvaMed, The Medtech Association®, and CapView Strategies released a white paper detailing ways to help advance the ethical incorporation of innovative artificial intelligence (AI) and software solutions into Medicare coverage…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
AdvaMed, The Medtech Association®, submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the Transitional Coverage for Emerging Technologies (TCET) notice.